142 related articles for article (PubMed ID: 15758)
1. Pharmacokinetics of beta-receptor-blocking agents in relation to their anti-hypertensive effect.
Gugler R; Bodem G; Dengler HJ
Clin Sci Mol Med Suppl; 1976 Dec; 3():473s-475s. PubMed ID: 15758
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Levy JV
Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
4. Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Meier J
Acta Med Scand Suppl; 1977; 606():65-70. PubMed ID: 19931
[No Abstract] [Full Text] [Related]
5. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
Shand DG
Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
[No Abstract] [Full Text] [Related]
6. Beta-adrenergic receptor blocking drugs in hypertension.
Simpson FO
Drugs; 1974; 7(1):85-105. PubMed ID: 4152167
[No Abstract] [Full Text] [Related]
7. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of oxprenolol in normal subjects.
Mason WD; Winer N
Clin Pharmacol Ther; 1976 Oct; 20(4):401-12. PubMed ID: 10124
[TBL] [Abstract][Full Text] [Related]
9. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Horii D; Kawada T; Takeda K; Imai S
Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
[No Abstract] [Full Text] [Related]
10. Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.
Aellig WH; Nüesch E; Engel G; Grevel J; Niederberger W; Rosenthaler J
Br J Clin Pharmacol; 1986 Jan; 21(1):45-51. PubMed ID: 2868747
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of pamatolol, a cardioselective beta adrenoreceptor blocker.
Carruthers SG; Pentikainen P; Hosler JP; Azarnoff DL
Clin Pharmacol Ther; 1979 Dec; 26(6):682-5. PubMed ID: 40725
[TBL] [Abstract][Full Text] [Related]
12. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
Salimi M
Pharmacology; 1975; 13(5):441-7. PubMed ID: 1802
[TBL] [Abstract][Full Text] [Related]
13. Relationship of propranolol pharmacokinetics to antihypertensive effect and beta-adrenergic blockade in the treatment of hypertension.
Krediet RT; Dunning AJ; Offerhaus L
Eur J Clin Pharmacol; 1980 Nov; 18(5):391-4. PubMed ID: 6108222
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology of pindolol.
Aellig WH
Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
[TBL] [Abstract][Full Text] [Related]
15. [Comparative pharmacokinetics of beta-blockers].
Kiechel JR; Meier J
Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
[No Abstract] [Full Text] [Related]
16. Beta-adrenergic receptor blocking drugs in angina pectoris.
Prichard BN
Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
[No Abstract] [Full Text] [Related]
17. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Antonaccio MJ; High J; DeForrest JM; Sybertz E
J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
[TBL] [Abstract][Full Text] [Related]
18. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
McDevitt DG; Brown HC; Carruthers SG; Shanks RG
Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
[TBL] [Abstract][Full Text] [Related]
20. The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
Day MD; Roach AG
Clin Sci Mol Med Suppl; 1975 Jun; 2():269s-272s. PubMed ID: 28878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
